Monthly Archives: October 2011

Biotech IPO Window – Still Ajar?

IPO plans for Quark Pharmaceuticals were officially put on hold last week as markets continue to drop and investors shy away from risk. This is the fifth IPO withdrawal since June. Ambit, Agendia and Clarus cited market reasons for their withdrawals, and Advanced BioHealing sought a higher valuation exit via acquisition. Only one biotech IPO, Horizon Pharma, has made it out in the last six months. Of the nine biotech IPOs so far in 2011, Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , ,

Policies that Benefit Start-Ups Grow the Bio-Economy

lab

The United States remains the land of entrepreneurialism despite our lingering economic troubles. To maintain our nation’s global leadership and drive job growth, we must continue to create policies that encourage and reward innovation in growth industries — including biotechnology. Jeffrey Bussgang, a general partner at the venture capital firm Flybridge Capital Partners contributed an interesting piece to Fortune/CNN Money in which he points out that start-up companies – not small businesses – are the Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , ,

PEW Study: Advanced Biofuels Can Help Military Respond to Energy Challenges

Blue Angel Refueling

PEW Charitable Trusts this week launched a new study, From Barracks to the Battlefield: Clean Energy Innovation and America’s Armed Forces, that details how energy innovation and clean energy can help U.S. Armed Forces respond to energy challenges and in turn how DoD’s commitment to energy transformation can contribute to development of new energy technologies that will benefit American consumers and commercial interests alike. The major energy challenges the DOD faces include risks associated with Read More >

Biofuels & Climate Change  |  Leave a comment  |  Email This Post
Tags: , , , , ,